Intelligence Platform
Patents
Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6251903
Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use there
expired patentUS 6251878
Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotectiv
expired patentUS 6251871
P16 expression constructs and their application in cancer therapy
expired patentUS 6251861
Treatment of cerebral infarction using cyclic hexapeptides
expired patentUS 6251858
Derivatives of oligosides, their process of preparation and their applications
expired patentUS 6251396
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic pr
expired patentUS 6251362
Method of establishing the optimal radiation dose
expired patentUS 6251924
Pharmaceutical composition
expired patentUS 6248888
Process for the preparation of terazosin hydrochloride dihydrate
expired patentUS 6248791
Stimulating the differentiation of preadipocytic cells and therapies based thereon
expired patentUS 6248749
Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acu
expired patentUS 6248740
Condensed pyridazine derivatives, their production and use
expired patentUS 6248528
Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
expired patentUS 6248357
Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubilit
expired patentUS 6245362
Medication for treatment of viral disease based on active agents of plant hypericum (St. J
expired patentUS 6245899
Composition for detection of cell density signal molecule
expired patentUS 6245892
Invaplex from gram negative bacteria, method of purification and methods of use
expired patentUS 6245752
Compositions and methods for tolerization in immune complex-mediated disease progression
expired patentUS 6245563
Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxi
expired patentUS 6245560
Vector with multiple target response elements affecting gene expression
expired patentUS 6245351
Controlled-release composition
expired patentUS 6242473
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
expired patentUS 6242486
Long chain carboxybetaines in antimicrobial formulations
expired patentUS 6242482
Prostaglandin compounds and derivatives thereof, compositions containing the same and meth
expired